Drugs / Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00601835 Comparator | May 2004 → Jul 2005 | diphtheria, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00601835 ↗ |
| Modality | Vaccine | “Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine” NCT00601835 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular, Single dose” NCT00601835 ↗ |